Cerebral Palsy: Bioness touts FDA win for treatment of foot drop in children

January 25, 2013 by MassDevice staff

Medical device company Bioness wins an FDA nod to market its neurostimulation treatment for foot drop in children.


Valencia, Calif.-based neurostimulation devices maker Bioness Inc. won the FDA's OK for its L300 Foot Drop system, the 1st FDA-cleared device of its kind for treating children suffering from foot drop as a result of cerebral palsy or other brain injuries.

The L300 neurostimulation device, which is available for sale immediately, "sends low-level electrical stimulation to the nerves in the lower leg which control the muscles responsible for lifting the foot," according to a prepared release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.